Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast CancerShanu Modi, David Cameron, María Vidal et al.|New England Journal of Medicine|2022Cited by 2.5k
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancerP. Tarantino, G. Curigliano, Giulia Viale et al.|Annals of Oncology|2023Cited by 298